Top 5 Drug Type | Count |
---|---|
AAV based gene therapy | 1 |
Gene therapy | 1 |
Top 5 Target | Count |
---|---|
LMNA(lamin A/C) | 1 |
Target- |
Mechanism Gene transference |
Active Org. Nuevocor Pte Ltd.Startup |
Originator Org. Nuevocor Pte Ltd.Startup |
Active Indication |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target |
Mechanism LMNA modulators |
Active Org. Nuevocor Pte Ltd.Startup |
Originator Org. Nuevocor Pte Ltd.Startup |
Active Indication |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
Adeno associated virus based gene therapy (Nuevocor) | Cardiomyopathy, Dilated More | Preclinical |
Adeno-associated virus based cardiomyopathy gene therapies (Nuevocor) ( LMNA ) | Cardiomyopathies More | Preclinical |